The Government wants patients to access cost-effective innovative medicines and technologies, which may include emerging treatments for muscle-wasting conditions, at a price that the National Health Service can afford. That is why we commissioned the Accelerated Access Review, which reported in October last year. We are considering the review\u2019s recommendations and will respond in due course.<\/p>
<\/p>
As part of the exit negotiations the Government will discuss with the European Union and Member States how best to continue cooperation on medicine research and development and regulation in the best interests of both the United Kingdom and the EU. It would not be appropriate to pre-judge the outcome of the negotiations, but we are clear that whatever happens NHS patients should have access to cost-effective life-changing treatments as soon as possible.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2017-06-29", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-06-29T11:03:21.133Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-06-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Neuromuscular Disorders"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what proposals he has made to ensure that patients do not experience delays in accessing emerging treatments for muscle-wasting conditions after the UK leaves the EU.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4488", "label" : {"_value" : "Biography information for Martyn Day"} } , "tablingMemberConstituency" : {"_value" : "Linlithgow and East Falkirk"} , "tablingMemberPrinted" : [{"_value" : "Martyn Day"} ], "uin" : "1192"} , {"_about" : "http://data.parliament.uk/resources/731287", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/731287/answer", "answerText" : {"_value" : "
We are monitoring the impact on the National Health Service.<\/p>
<\/p>
The latest NHS Digital data available on nationality shows the number of nurses with European Union (excluding United Kingdom) nationalities (EU27) has increased by over 400 between June 2016 and March 2017. This number as a percentage of all nurses has also increased slightly, from 6.9% to 7.0%.<\/p>
<\/p>
NHS Digital publishes data on the nationality of staff working in the National Health Service in England. Nationality is self-reported within the NHS human resources and payroll system, the electronic staff record.<\/p>
<\/p>
The Secretary of State has repeatedly said that overseas workers form a crucial part of our NHS and we value their contribution immensely.<\/p>
<\/p>
We understand the need to give valued NHS staff from the EU certainty, which is why securing an agreement that will guarantee the status of EU nationals here and UK nationals in the EU is one of our top priorities in Brexit negotiations.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1542", "label" : {"_value" : "Biography information for Philip Dunne"} } , "answeringMemberConstituency" : {"_value" : "Ludlow"} , "answeringMemberPrinted" : {"_value" : "Mr Philip Dunne"} , "dateOfAnswer" : {"_value" : "2017-06-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-06-27T15:30:12.993Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-06-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Nurses: Migrant Workers"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the effect of the UK leaving the EU on the number of nurses from the EU working in the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4488", "label" : {"_value" : "Biography information for Martyn Day"} } , "tablingMemberConstituency" : {"_value" : "Linlithgow and East Falkirk"} , "tablingMemberPrinted" : [{"_value" : "Martyn Day"} ], "uin" : "61"} , {"_about" : "http://data.parliament.uk/resources/731332", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/731332/answer", "answerText" : {"_value" : "
The burden of musculoskeletal (MSK) conditions is likely to rise significantly due to an ageing population and a combination of obesity and physical inactivity. Individual clinical commissioning groups (CCGs) and local authorities (LAs) are responsible for the delivery of services to treat and support the prevention of MSK disorders from their respective resources allocation. Where appropriate, some local services may be designed and delivered in partnership between CCGs and LAs.<\/p>
Whilst not all MSK conditions are preventable, physical activity can play an important part in reducing risk of developing certain MSK disorders and managing MSK symptoms. Regular physical activity that meets national guidelines on frequency and intensity can reduce an individual\u2019s risk of developing joint and back pain by 25% and can improve symptoms for people with MSK conditions.<\/p>
The Department works with Public Health England (PHE), NHS England and local authorities to promote physical activity. The \u2018Providing physical activity interventions for people with musculoskeletal conditions\u2019 report, published in March 2017 is the result of collaboration between Arthritis Research UK, PHE, NHS England and the Department. The report reviews the benefits of physical activity both for people with MSK conditions and wider society and provides a framework that supports a tiered approach to intervention. More information can be found at the following link:<\/p>
www.arthritisresearchuk.org/policy-and-public-affairs/reports-and-resources/reports/physical-activity-report.aspx<\/a><\/p> PHE is leading the discussions to engage all partners and stakeholders to prevent, detect and treat MSK conditions at an earlier stage through the use of evidence based interventions. For the whole population, the Government and PHE are also working to promote and support lifestyles that encourage people to make informed healthy choice in their approach to physical activity and eating a healthy diet, in order to promote overall wellbeing as well as reduce their risk of developing MSK conditions and to maintain and enhance bone health.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2017-06-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-06-27T10:30:34.09Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-06-21", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Musculoskeletal Disorders"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to tackle the increase in the number of people diagnosed with arthritis and other musculoskeletal disorders in relation to (a) funding and (b) public health strategy.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4488", "label" : {"_value" : "Biography information for Martyn Day"}
}
, "tablingMemberConstituency" : {"_value" : "Linlithgow and East Falkirk"}
, "tablingMemberPrinted" : [{"_value" : "Martyn Day"}
], "uin" : "254"}
, {"_about" : "http://data.parliament.uk/resources/694234", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/694234/answer", "answerText" : {"_value" : " The recommendations made by The Brain Tumour Charity in its report and guidance align with the recommendations in the independent Cancer Taskforce\u2019s 2015 report, Achieving World-Class Cancer Outcomes: A strategy for England 2015-20201<\/sup><\/em>, which represented the consensus views of the whole cancer community.<\/p> <\/p> Improving early diagnosis of cancer is a priority for this Government. We have committed to delivering the independent Taskforce\u2019s recommendations on early diagnosis, including the introduction of a 28 day waiting times standard. NHS England\u2019s Accelerate, Co-ordinate, Evaluate programme is testing innovative ways of diagnosing cancer earlier. The second wave of the programme is piloting multi-disciplinary diagnostic centres for patients with vague or non-specific symptoms. The pilots are taking place in London, Greater Manchester, Leeds, Bristol, Oxfordshire and Airedale, Wharfedale and Craven (Yorkshire).<\/p> <\/p> Additionally, patient experience was one of the six strategic priorities identified by the independent Cancer Taskforce, and \u2018overall patient experience\u2019 is one of the four key metrics included in the Clinical Commissioning Group Improvement and Assessment Framework published for the first time in 2016.<\/p> <\/p> A new Department of Health Task and Finish Working Group on Brain Tumour Research is bringing together clinicians, charities, patients, and officials to discuss how, working together with research funding partners, we can address the need to increase the level and impact of research into brain tumours. The Working Group is chaired by Professor Chris Whitty, the Department's Chief Scientific Adviser. The Working Group met for the second time on 30 January, and plans to report to the Parliamentary Under Secretary of State for Public Health and Innovation by summer 2017.<\/p> <\/p> The Department\u2019s National Institute for Health Research (NIHR) supports brain tumour clinical trials via its Biomedical Research Centres, Clinical Research Facilities, and its Clinical Research Network (CRN). The CRN comprises 15 Local CRNs (LCRNs). In a new initiative from April 2015, each of these LCRNs has designated a senior clinician as the Subspecialty Lead for Brain Tumours. These local leaders are liaising with the National Cancer Research Institute\u2019s Clinical Studies Groups to help plan the development and delivery of the national portfolio of brain tumour research, identifying new research opportunities and areas of clinical need. In the financial year 2015/16 the NIHR CRN supported recruitment of 1,061 patients to 37 brain cancer studies.<\/p> <\/p> To support people after treatment ends, in December 2016, NHS England announced a fund of over £200 million available to Cancer Alliances over the next two years, specifically to support those areas of the Cancer Taskforce strategy that it estimated would need significant investment. This includes implementation of the Recovery Package so that patients have personalised care and support from the point they are diagnosed to improve their quality of life.<\/p> <\/p> The report also included recommendations on palliative care. The Government\u2019s ambition is for everyone approaching the end of life to receive high quality care that reflects their individual needs, choices and preferences. On 5 July 2016, we set out plans to improve end of life care in England. Our proposals are based on a commitment to high quality, personalised end of life care that we are making to all people at, or approaching the end of life.<\/p> <\/p> Note:<\/p> <\/p>